BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Elotuzumab receives positive CHMP opinion for the treatment of multiple myeloma
Feb. 1, 2016
Phase III Opdivo trial meets endpoint, stopped early
Jan. 29, 2016
Avax Technologies announces results of its OVAX phase I/II clinical trial
Jan. 29, 2016
Cyramza approved in Europe for NSCLC and colorectal cancer
Jan. 28, 2016
Prima BioMed starts phase I study of IMP-321 for the treatment of melanoma
Jan. 27, 2016
FDA puts Medivation's pidilizumab on clinical hold
Jan. 27, 2016
OncoMed unblinds phase II trial of tarextumab following DSMB analysis
Jan. 26, 2016
Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma
Jan. 25, 2016
Immunocore's IMCgp-100 gets FDA orphan drug designation for uveal melanoma
Jan. 25, 2016
FDA clears IND application for Agenus' anti-CTLA-4 and anti-GITR antibodies
Jan. 25, 2016
Previous
1
2
…
586
587
588
589
590
591
592
593
594
…
1003
1004
Next
RSS